Deepak Parajuli

Mr. Deepak Parajuli

Department of Chemical Engineering, Universitat Rovira i Virgili (URV), Tarragona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2016 in Virtual and Physical Prototyping
Verified
Journal Article
Closed access
DPDeepak Parajuli
Deepak Parajuli
PKPisut Koomsap
Pisut Koomsap
APAlok A. Parkhi
Alok A. Parkhi
PSPitt Supaphol
Pitt Supaphol
Near-field electrospinning (NFES) with its capability to produce a straight fine fibre has been integrated into additive manufacturing for the fabrication of scaffolds with controllable pattern structures. However, building the third dimension with NFES is not easy due to the unsolidified fibre while being deposited. Presented in this paper is an investigation on the influence of process parameters on achieving a small cylindrical fibre from the near-field fibre deposition of an electrospinning-based rapid prototyping. A set of experiments have been conducted on solutions of polycaprolactone (PCL) in N,N-dimethylformamide (DMF). Parameters of interest are voltage, standoff distance, polymer concentration, environmental condition and needle size. From the experimental results, polymer concentration, environmental condition and needle size had influence on achieving a small cylindrical fibre. Under near-field deposition, the concentration should be high, the needle should be small and the temperature should be maintained during the process.

Verified
Journal Article
Open access
PDF file
YPYaride Pérez Pacheco
Yaride Pérez Pacheco
DPDeepak Parajuli
Deepak Parajuli
Ricard Garcia-VallsRicard Garcia-Valls
Ricard Garcia-Valls
Chronic diseases such as cancer, cardiovascular disorders, neurodegenerative conditions, chronic respiratory diseases, autoimmune disorders, chronic kidney disease, persistent infectious diseases, diabetes, and ocular inflammation remain leading causes of morbidity and mortality worldwide. Their complex pathophysiologies and the limitations of conventional therapies underscore the urgent need for advanced drug delivery platforms that enhance therapeutic efficacy while minimizing off-target effects and systemic toxicity leading to adverse reactions. Nanomedicine has emerged as a transformative approach, with chitosan-based nanocarriers offering advantages due to their biocompatibility, biodegradability, mucoadhesive properties, and ability to be physic-chemically modified. These nanocarriers improve solubility, stability, bioavailability, and the therapeutic index of drugs, while enabling controlled release, targeted delivery, and immune modulation. This review highlights recent advances in chitosan-based nanomedicine for the management of chronic disease. We discuss methods of synthesis such as ionic gelation and electrospray, functionalization approaches, and immunomodulatory roles that expand therapeutic potential. The evidence emphasizes that chitosan nanocarriers are a versatile, safe, and effective platform which can be used to improve clinical results, reduce adverse effects, and advance the science of personalized medicine.

20 March 2021 in Bulletin of Materials Science
Verified
Journal Article
Closed access
PDF file
SBSudipta Bain
Sudipta Bain
PKPisut Koomsap
Pisut Koomsap
DPDeepak Parajuli
Deepak Parajuli

22 February 2023 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
KEKomgrit Eawsakul
Komgrit Eawsakul
DPDeepak Parajuli
Deepak Parajuli
NWNattarat Wongsuwan
Nattarat Wongsuwan
NNNorased Nasongkla
Norased Nasongkla
The most suitable method to treat hydrocephalus disease is to insert a shunt catheter that drains the cerebral spinal fluid (CSF); however, shunt implantation is often associated with various bacterial infections. In this study, antibiotic-loaded nanospheres were prepared using the solvent evaporation technique and coated on an antibiotic-impregnated shunt surface to promote shunt antibacterial properties. Clindamycin (CDM) and rifampicin (RIF) were in combination loaded in a single nanosphere, whereas trimethoprim (TMP) was loaded individually in triblock copolymers [(d,l-lactide-random-ε-caprolactone)-block-poly(ethylene glycol)-block-(d,l-lactide-random-ε-caprolactone)] (PLEC). The drug-loading content, encapsulation efficiency, yield, size, and zeta potential of the antibiotic-loaded nanospheres were measured. The results showed that the drug-loading content of clindamycin- and rifampicin-loaded nanospheres (CDM/RIF-NPs) was approximately 3% and 8%, respectively, at a drug to polymer ratio of 1:2. In addition, trimethoprim-loaded nanospheres (TMP-NPs) showed nearly 7% drug loading at equal drug and polymer ratios. The amount of drug release was determined before and after the coating of nanospheres on the shunt surface. In addition, in silico molecular docking studies indicated the good chemical interaction of these antibiotics with PLEC, and the results were consistent with those of impregnation studies. Antibacterial tests of coated external ventricular drainage showed antibacterial activity for up to 21 days.

14 July 2026 in Journal of Electrostatics
Verified
Journal Article
Open access
DPDeepak Parajuli
Deepak Parajuli
EBEszter Bodnár
Eszter Bodnár
JRJoan Rosell-Llompart
Joan Rosell-Llompart